Drug profile · INN
elotuzumab
EMPLICITI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
elotuzumab (EMPLICITI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN elotuzumab
Brand EMPLICITI
Route INJECTION
Formulation INJECTABLE
ATC code L01FX08
Frequently asked questions
What is elotuzumab?
elotuzumab (EMPLICITI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for elotuzumab?
EMPLICITI is a marketed brand name for elotuzumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of elotuzumab?
elotuzumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.